HSBC Holdings
COLL icon

HSBC Holdings’s Collegium Pharmaceutical COLL Stock Holding History

HSBC Holdings’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
39,609
+12,015
+44% +$411K ﹤0.01% 1755
2026
Q1 		$905K Sell
27,594
-3,260
-11% -$138K ﹤0.01% 1924
2025
Q4 		$1.43M Buy
30,854
+13,520
+78% +$566K ﹤0.01% 1738
2025
Q3 		$613K Buy
17,334
+2,809
+19% +$97.6K ﹤0.01% 2003
2025
Q2 		$427K Sell
14,525
-9,162
-39% -$261K ﹤0.01% 2233
2025
Q1 		$703K Buy
23,687
+6,808
+40% +$208K ﹤0.01% 1914
2024
Q4 		$483K Sell
16,879
-576
-3% -$19.1K ﹤0.01% 2201
2024
Q3 		$675K Sell
17,455
-3,133
-15% -$112K ﹤0.01% 1866
2024
Q2 		$663K Sell
20,588
-726
-3% -$25.2K ﹤0.01% 1845
2024
Q1 		$827K Buy
21,314
+13,570
+175% +$475K ﹤0.01% 1862
2023
Q4 		$239K Buy
+7,744
New +$194K ﹤0.01% 2386
2023
Q2 		– Sell
-8,284
Closed -$201K – 2587
2023
Q1 		$201K Sell
8,284
-5,603
-40% -$149K ﹤0.01% 2395
2022
Q4 		$322K Buy
13,887
+1,800
+15% +$36.3K ﹤0.01% 2502
2022
Q3 		$197K Buy
12,087
+1,778
+17% +$31.4K ﹤0.01% 2635
2022
Q2 		$183K Buy
+10,309
New +$173K ﹤0.01% 2910
2021
Q3 		– Sell
-13,235
Closed -$316K – 3012
2021
Q2 		$316K Buy
13,235
+3,950
+43% +$91.3K ﹤0.01% 2481
2021
Q1 		$222K Buy
+9,285
New +$221K ﹤0.01% 2492

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

HSBC Holdings's COLL Position: Q2 2026 in Review

HSBC Holdings increased its Collegium Pharmaceutical (COLL) stake by 44% in Q2 2026, buying an estimated $411K and bringing the position to 39,609 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

HSBC Holdings first reported a position in COLL in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.43M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • HSBC Holdings held 39,609 shares of Collegium Pharmaceutical worth $1.42M as of Q2 2026.
  • HSBC Holdings bought 12,015 Collegium Pharmaceutical shares in Q2 2026, an estimated $411K.
  • Collegium Pharmaceutical made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1755 holding.
  • HSBC Holdings first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 17 quarters since.
  • HSBC Holdings's Collegium Pharmaceutical position peaked at $1.43M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.